Treating in the dark: unanswered questions on costs and benefits of late line therapy for metastatic breast cancer
- PMID: 19160108
- DOI: 10.1080/07357900802484944
Treating in the dark: unanswered questions on costs and benefits of late line therapy for metastatic breast cancer
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical